Cargando…

Next-Generation Sequencing in Veterinary Medicine: How Can the Massive Amount of Information Arising from High-Throughput Technologies Improve Diagnosis, Control, and Management of Infectious Diseases?

The development of high-throughput molecular technologies and associated bioinformatics has dramatically changed the capacities of scientists to produce, handle, and analyze large amounts of genomic, transcriptomic, and proteomic data. A clear example of this step-change is represented by the amount...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Borm, Steven, Belák, Sándor, Freimanis, Graham, Fusaro, Alice, Granberg, Fredrik, Höper, Dirk, King, Donald P., Monne, Isabella, Orton, Richard, Rosseel, Toon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123048/
https://www.ncbi.nlm.nih.gov/pubmed/25399113
http://dx.doi.org/10.1007/978-1-4939-2004-4_30
_version_ 1783515550870142976
author Van Borm, Steven
Belák, Sándor
Freimanis, Graham
Fusaro, Alice
Granberg, Fredrik
Höper, Dirk
King, Donald P.
Monne, Isabella
Orton, Richard
Rosseel, Toon
author_facet Van Borm, Steven
Belák, Sándor
Freimanis, Graham
Fusaro, Alice
Granberg, Fredrik
Höper, Dirk
King, Donald P.
Monne, Isabella
Orton, Richard
Rosseel, Toon
author_sort Van Borm, Steven
collection PubMed
description The development of high-throughput molecular technologies and associated bioinformatics has dramatically changed the capacities of scientists to produce, handle, and analyze large amounts of genomic, transcriptomic, and proteomic data. A clear example of this step-change is represented by the amount of DNA sequence data that can be now produced using next-generation sequencing (NGS) platforms. Similarly, recent improvements in protein and peptide separation efficiencies and highly accurate mass spectrometry have promoted the identification and quantification of proteins in a given sample. These advancements in biotechnology have increasingly been applied to the study of animal infectious diseases and are beginning to revolutionize the way that biological and evolutionary processes can be studied at the molecular level. Studies have demonstrated the value of NGS technologies for molecular characterization, ranging from metagenomic characterization of unknown pathogens or microbial communities to molecular epidemiology and evolution of viral quasispecies. Moreover, high-throughput technologies now allow detailed studies of host-pathogen interactions at the level of their genomes (genomics), transcriptomes (transcriptomics), or proteomes (proteomics). Ultimately, the interaction between pathogen and host biological networks can be questioned by analytically integrating these levels (integrative OMICS and systems biology). The application of high-throughput biotechnology platforms in these fields and their typical low-cost per information content has revolutionized the resolution with which these processes can now be studied. The aim of this chapter is to provide a current and prospective view on the opportunities and challenges associated with the application of massive parallel sequencing technologies to veterinary medicine, with particular focus on applications that have a potential impact on disease control and management.
format Online
Article
Text
id pubmed-7123048
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-71230482020-04-06 Next-Generation Sequencing in Veterinary Medicine: How Can the Massive Amount of Information Arising from High-Throughput Technologies Improve Diagnosis, Control, and Management of Infectious Diseases? Van Borm, Steven Belák, Sándor Freimanis, Graham Fusaro, Alice Granberg, Fredrik Höper, Dirk King, Donald P. Monne, Isabella Orton, Richard Rosseel, Toon Veterinary Infection Biology: Molecular Diagnostics and High-Throughput Strategies Article The development of high-throughput molecular technologies and associated bioinformatics has dramatically changed the capacities of scientists to produce, handle, and analyze large amounts of genomic, transcriptomic, and proteomic data. A clear example of this step-change is represented by the amount of DNA sequence data that can be now produced using next-generation sequencing (NGS) platforms. Similarly, recent improvements in protein and peptide separation efficiencies and highly accurate mass spectrometry have promoted the identification and quantification of proteins in a given sample. These advancements in biotechnology have increasingly been applied to the study of animal infectious diseases and are beginning to revolutionize the way that biological and evolutionary processes can be studied at the molecular level. Studies have demonstrated the value of NGS technologies for molecular characterization, ranging from metagenomic characterization of unknown pathogens or microbial communities to molecular epidemiology and evolution of viral quasispecies. Moreover, high-throughput technologies now allow detailed studies of host-pathogen interactions at the level of their genomes (genomics), transcriptomes (transcriptomics), or proteomes (proteomics). Ultimately, the interaction between pathogen and host biological networks can be questioned by analytically integrating these levels (integrative OMICS and systems biology). The application of high-throughput biotechnology platforms in these fields and their typical low-cost per information content has revolutionized the resolution with which these processes can now be studied. The aim of this chapter is to provide a current and prospective view on the opportunities and challenges associated with the application of massive parallel sequencing technologies to veterinary medicine, with particular focus on applications that have a potential impact on disease control and management. 2014-08-11 /pmc/articles/PMC7123048/ /pubmed/25399113 http://dx.doi.org/10.1007/978-1-4939-2004-4_30 Text en © Springer Science+Business Media New York 2015 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Van Borm, Steven
Belák, Sándor
Freimanis, Graham
Fusaro, Alice
Granberg, Fredrik
Höper, Dirk
King, Donald P.
Monne, Isabella
Orton, Richard
Rosseel, Toon
Next-Generation Sequencing in Veterinary Medicine: How Can the Massive Amount of Information Arising from High-Throughput Technologies Improve Diagnosis, Control, and Management of Infectious Diseases?
title Next-Generation Sequencing in Veterinary Medicine: How Can the Massive Amount of Information Arising from High-Throughput Technologies Improve Diagnosis, Control, and Management of Infectious Diseases?
title_full Next-Generation Sequencing in Veterinary Medicine: How Can the Massive Amount of Information Arising from High-Throughput Technologies Improve Diagnosis, Control, and Management of Infectious Diseases?
title_fullStr Next-Generation Sequencing in Veterinary Medicine: How Can the Massive Amount of Information Arising from High-Throughput Technologies Improve Diagnosis, Control, and Management of Infectious Diseases?
title_full_unstemmed Next-Generation Sequencing in Veterinary Medicine: How Can the Massive Amount of Information Arising from High-Throughput Technologies Improve Diagnosis, Control, and Management of Infectious Diseases?
title_short Next-Generation Sequencing in Veterinary Medicine: How Can the Massive Amount of Information Arising from High-Throughput Technologies Improve Diagnosis, Control, and Management of Infectious Diseases?
title_sort next-generation sequencing in veterinary medicine: how can the massive amount of information arising from high-throughput technologies improve diagnosis, control, and management of infectious diseases?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123048/
https://www.ncbi.nlm.nih.gov/pubmed/25399113
http://dx.doi.org/10.1007/978-1-4939-2004-4_30
work_keys_str_mv AT vanbormsteven nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases
AT belaksandor nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases
AT freimanisgraham nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases
AT fusaroalice nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases
AT granbergfredrik nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases
AT hoperdirk nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases
AT kingdonaldp nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases
AT monneisabella nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases
AT ortonrichard nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases
AT rosseeltoon nextgenerationsequencinginveterinarymedicinehowcanthemassiveamountofinformationarisingfromhighthroughputtechnologiesimprovediagnosiscontrolandmanagementofinfectiousdiseases